Base de dados : LILACS
Pesquisa : D08.811.277.656.675.374.102.500.844 [Categoria DeCS]
Referências encontradas : 1 [refinar]
Mostrando: 1 .. 1   no formato [Detalhado]

página 1 de 1

  1 / 1 LILACS  
para imprimir
Texto completo
Id: biblio-1024773
Autor: Lima, M A; Dos Santos, L; Turri, J A; Nonogaki, S; Buim, M; Lima, J F; de Jesus Viana Pinheiro, J; Osório, C A Bueno de Toledo; Soares, F A; Freitas, V M.
Título: Prognostic Value of ADAMTS Proteases and Their Substrates in Epithelial Ovarian Cancer
Fonte: Pathobiology;83(6):316-326, 2016.
Idioma: en.
Resumo: Background: ADAMTS are metalloproteases with disintegrin and thrombospondin motifs. They are secreted proteases playing a role in biological processes such as inflammation, angiogenesis, and urogenital development. ADAMTS have specific substrates, such as the proteoglycans (PG) versican, aggrecan, and brevican. Despite data indicating a role of ADAMTS in tumor invasion and metastases, effects played by these molecules in cancer progression are still controversial. In ovarian cancer, the importance of ADAMTS gene mutations was recently described and related to chemotherapy outcome. Objective: To analyze protein levels of ADAMTS-1, -4, and -5, and TIMP-3 in human ovarian cancer classified as benign, borderline, or malignant. We also assessed the expression of the ADAMTS substrates aggrecan, brevican, and versican in these neoplasms. Correlations between overall survival and protein expression were performed. Methods: Tumors were classified according to the WHO Classification of Tumors of Female Reproductive Organs. Protein and PG expression was studied by immunohistochemistry. Differences in labeling were analyzed by percent measurements of stained areas. Results: ADAMTS-1, ADAMTS-5, and its tissue inhibitor TIMP-3 are increased in borderline and malignant tumors compared to benign neoplasms. Aggrecan and versican levels were increased in malignant subtypes compared to benign ovarian cancer. Higher ADAMTS-1, TIMP-3, and versican expression was associated with a shorter overall survival. Conclusions: Comparison of protease, TIMP-3, and substrate expression showed that in malignant tumors all ADAMTS and TIMP-3 expression levels were significantly raised compared to the substrates studied.
Descritores: Neoplasias Ovarianas
Biomarcadores Tumorais/metabolismo
Regulação Neoplásica da Expressão Gênica
Neoplasias Epiteliais e Glandulares/diagnóstico
Inibidor Tecidual de Metaloproteinase-3/metabolismo
Proteína ADAMTS1/metabolismo
Proteína ADAMTS4/metabolismo
Responsável: BR91.2 - Centro de Documentação

página 1 de 1

Refinar a pesquisa
  Base de dados : Formulário avançado   

    Pesquisar no campo  

Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde